Osiris Therapeutics Inc. (PINK:OSIR)
Industry: Healthcare

OFF LIST - 987 consecutive market days: OFF LIST as of 07/03/2012 Through 11/14/2016

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns; BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery; and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects. It markets and distributes its products directly to hospitals, clinics, and physician offices as well as through agents and distributors. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

Current Quote*
Last: $4.719
Change: 0.019
Book: $4.500
Volume: 78,952

As Of: 04/21 19:14 ET
*Quotes delayed by 20min.

Graphs for OSIR


3 Month Graph


6 Month Graph


1 Year Graph